{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:05:40Z","timestamp":1773457540126,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jtocrr.2025.100846","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:40:26Z","timestamp":1747338026000},"page":"100846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histologic Grade 3 in Stage 1A Lung Adenocarcinoma: Survival Risks Comparable to Stage 1B"],"prefix":"10.1016","volume":"7","author":[{"given":"Gyerim","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngkyu","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meejeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyo Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeoun Eun","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2025.100846_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jtocrr.2025.100846_bib2","first-page":"242","article-title":"Recurrence after surgery in patients with NSCLC","volume":"3","author":"Uramoto","year":"2014","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtocrr.2025.100846_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/JTO.0b013e3181c20080","article-title":"Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure","volume":"5","author":"Boyd","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2025.100846_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0022-5223(95)70427-2","article-title":"Incidence of local recurrence and second primary tumors in resected stage I lung cancer","volume":"109","author":"Martini","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtocrr.2025.100846_bib5","series-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2015"},{"key":"10.1016\/j.jtocrr.2025.100846_bib6","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.jtocrr.2025.100846_bib7","series-title":"WHO Classification of Tumours: Thoracic Tumours","author":"Travis","year":"2021"},{"key":"10.1016\/j.jtocrr.2025.100846_bib8","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jtho.2020.06.001","article-title":"A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer pathology committee","volume":"15","author":"Moreira","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2025.100846_bib9","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jtcvs.2003.11.017","article-title":"Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment","volume":"127","author":"Shimizu","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtocrr.2025.100846_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa2304594","article-title":"Overall survival with osimertinib in resected EGFR-mutated NSCLC","volume":"389","author":"Tsuboi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtocrr.2025.100846_bib11","article-title":"Adjuvant immunotherapy in early-stage resectable non-small cell lung cancer: a new milestone","volume":"13","author":"Tang","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtocrr.2025.100846_bib12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s11864-022-01034-3","article-title":"Adjuvant immunotherapy in patients with early-stage non-small cell lung cancer and future directions","volume":"23","author":"Saw","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jtocrr.2025.100846_bib13","series-title":"Manual for Staging of Cancer","year":"1977"},{"key":"10.1016\/j.jtocrr.2025.100846_bib14","article-title":"Comparison of the 7(th) and proposed 8(th) editions of the AJCC\/UICC TNM staging system for non-small cell lung cancer undergoing radical surgery","volume":"6","author":"Jin","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtocrr.2025.100846_bib15","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.21037\/jtd-20-3509","article-title":"The prognostic utility of the histologic subtype of stage I lung adenocarcinoma may be diminished when using only the invasive component to determine tumor size for tumor node metastasis (TNM) staging","volume":"13","author":"Sung","year":"2021","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtocrr.2025.100846_bib16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/PAS.0b013e31827fcf04","article-title":"Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung","volume":"37","author":"Xu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtocrr.2025.100846_bib17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/his.13236","article-title":"Histological features of malignancy correlate with growth patterns and patient outcome in lung adenocarcinoma","volume":"71","author":"M\u00e4kinen","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.jtocrr.2025.100846_bib20","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.jtho.2021.04.008","article-title":"Validation study of the International Association for the Study of Lung Cancer histologic grading system of invasive lung adenocarcinoma","volume":"16","author":"Rokutan-Kurata","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2025.100846_bib21","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jtho.2021.06.031","article-title":"Grading in lung adenocarcinoma: another new normal","volume":"16","author":"Nicholson","year":"2021","journal-title":"J Thorac Oncol"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364325000633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364325000633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:27:13Z","timestamp":1773455233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364325000633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666364325000633"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2025.100846","relation":{},"ISSN":["2666-3643"],"issn-type":[{"value":"2666-3643","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histologic Grade 3 in Stage 1A Lung Adenocarcinoma: Survival Risks Comparable to Stage 1B","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2025.100846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100846"}}